Poehling Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.55M Buy
63,927
+1,506
+2% +$36.5K 0.36% 59
2025
Q1
$1.58M Buy
62,421
+2,408
+4% +$61K 0.4% 63
2024
Q4
$1.59M Buy
60,013
+714
+1% +$18.9K 0.39% 66
2024
Q3
$1.72M Sell
59,299
-40
-0.1% -$1.16K 0.44% 60
2024
Q2
$1.66M Buy
59,339
+4,923
+9% +$138K 0.45% 62
2024
Q1
$1.51M Buy
54,416
+4,609
+9% +$128K 0.4% 64
2023
Q4
$1.43M Sell
49,807
-10,536
-17% -$303K 0.45% 63
2023
Q3
$2M Sell
60,343
-16,739
-22% -$555K 0.7% 43
2023
Q2
$2.83M Buy
77,082
+15,097
+24% +$554K 0.96% 33
2023
Q1
$2.53M Buy
61,985
+10,638
+21% +$434K 0.85% 41
2022
Q4
$2.63M Sell
51,347
-1,447
-3% -$74.1K 0.99% 31
2022
Q3
$2.31M Buy
52,794
+3,653
+7% +$160K 0.97% 30
2022
Q2
$2.58M Buy
49,141
+1,002
+2% +$52.5K 0.97% 32
2022
Q1
$2.49M Buy
48,139
+6,212
+15% +$322K 0.77% 41
2021
Q4
$2.48M Sell
41,927
-36,604
-47% -$2.16M 0.8% 43
2021
Q3
$3.38M Sell
78,531
-2,838
-3% -$122K 1.14% 31
2021
Q2
$3.19M Buy
81,369
+529
+0.7% +$20.7K 1.01% 38
2021
Q1
$2.93M Buy
80,840
+2,746
+4% +$99.5K 1.03% 35
2020
Q4
$2.88M Sell
78,094
-796
-1% -$29.3K 1.14% 33
2020
Q3
$2.75M Sell
78,890
-779
-1% -$27.1K 1.41% 21
2020
Q2
$2.47M Buy
79,669
+10,611
+15% +$329K 1.33% 24
2020
Q1
$2.14M Buy
69,058
+63,399
+1,120% +$1.96M 1.57% 20
2019
Q4
$210K Buy
+5,659
New +$210K 0.14% 103
2018
Q3
Sell
-2,281
Closed -$79K 219
2018
Q2
$79K Sell
2,281
-206
-8% -$7.14K 0.07% 130
2018
Q1
$84K Buy
2,487
+1
+0% +$34 0.07% 118
2017
Q4
$85K Buy
+2,486
New +$85K 0.07% 121